Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The company is confident of addressing the concern raised by the USFDA
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3) targeting T-cell engager
Subscribe To Our Newsletter & Stay Updated
